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Introduction
Permanent congenital hearing loss (PCHL) is a major cause 
of disability worldwide affecting up to 6/1000 births.[1] This 
disease burden is highest in developing countries due to an 
increased prevalence of infectious disease and poor access 
to maternal healthcare. Furthermore, affected individuals are 
particularly vulnerable to social isolation and abuse due to the 
cultural beliefs about deafness and disability.[2] To date, there 
is no published work exploring newborn screening for hearing 
loss (NSHL) in Uganda.
NSHL faces many challenges to its successful implementation 
in developing countries. These include more limited access to 
audiological diagnostics and interventions, a high proportion 
of unattended home births and lower staffing levels. Therefore, 
it is important that NSHL protocols are appropriate for the 
resources and the healthcare infrastructure of each country. 
This concept is strongly encouraged by the World Health 
Organization, who advocate the implementation of NSHL 
program informed by local pilot projects.[3]
A key consideration for an NSHL program is when to screen 
the infants to ensure the best possible coverage. Uganda has 
a birth rate of 44/1000 population, one of the highest crude 
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Abstract
Background: Permanent congenital hearing loss affects up to 6/1000 births in developing 
countries. Currently, in Uganda there is no newborn screening for hearing loss (NSHL) 
program and no published work on this topic. Within the existing healthcare system there 
are two opportunities to deliver screening, at birth or 6 weeks of age when infants receive 
their immunizations. Aim: This study explored the outcomes of otoacoustic emission (OAE) 
testing in infants at birth and 6 weeks of age, to identify the optimal age for screening. 
Subjects and Methods: This cross‑sectional pilot study recruited 60 consecutive infants from 
two health centres in Kampala, Uganda. Thirty infants were newborns recruited from the 
postnatal ward and 30 were aged 4–8 weeks from the immunization clinic, we performed 
OAE testing on all infants. Results: The results showed 56.7% (17/30) of newborn infants 
passed OAE testing compared with 90.0% (27/30) of the immunization infants, P < 0.01. 
Furthermore, of the 11 newborn infants aged ≥24 h of age 90.9% (10/11) passed, compared 
with the 19 infants <24 h of age where 37% (7/19) passed, P < 0.01. Conclusions: This 
study demonstrates a higher pass rate for OAE testing for infants ≥24 h of age compared to 
those <24 h of age. The overall lower pass rate of the newborn infants could be due to external 
ear debris and middle ear fluid compromising the OAE testing. These findings would support 
a NSHL programme in Uganda that offers screening to infants ≥24 h of age, to maximize the 
cost‑effectiveness of the program.
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birth rates worldwide. Within Uganda most common place of 
birth shows significant geographical variability with 27.1% 
delivering in a health facility in Karamojo region compared 
with 92.9% in Kampala.[4,5] The first immunizations, bacillus 
Calmette–Guérin (BCG) and polio, are administered at birth 
prior to discharge from the health facility. The second set of 
immunizations are at 6 weeks of age and include diphtheria, 
pertussis and tetanus, hepatits B, haemophilus influenza B, and 
polio, with few infants receiving any clinical contact between 
the birth and this time point.[4] Infants born in the community 
receive their birth immunizations at the first point of contact, 
which is highly varied. The vaccination rate is more consistent 
across Uganda than the place of birth. In 2011, the rate for BCG 
vaccination in infants aged 12–23 months ranged from 85.2% 
in the Central region to 99.8% in Karamoja. Kampala’s BCG 
immunization rate at 12–23 months is reported as 94.6%, with 
92.7% of infants receiving it by 8 weeks of age.[4,6]
Screening protocols have a significant impact on the 
cost-effectiveness of an NSHL program. Countries with an 
operational NSHL program include the UK, Germany, Canada, 
the United States, and Brazil and commonly use a combination 
of otoacoustic emission (OAE) and auditory brainstem response 
(ABR). OAE testing is a quick and low cost, but generates 
a higher numbers of false positives when compared with 
automated-ABR (A-ABR). Combining these two tests generates 
an effective screening protocol while limiting cost, however, 
for some developing countries the cost of A-ABR remains 
prohibitive.[7,8] Worldwide screening is largely performed in the 
newborn nursery with the first screening test performed from birth 
until approximately 10 days of age.[3] Newborn screening at a very 
young age has been shown to increase the false positive rate of 
OAE testing, especially in those <48 h of age.[9] These findings 
can be attributed to impaired conduction of the OAEs through 
the ear due to ear canal debris, middle ear fluid, and anatomical 
distortions of the external ear impacting ear probe fit.[9-12] 
Initiating screening in the immediate postnatal period facilitates 
a prompt diagnosis and timely intervention for affected infants. 
This allows NSHL programs to initiate appropriate interventions 
by 6 months of age, in keeping with the recommendations of the 
Joint Committee on Infant Hearing (JCIH).[13]
This study explores the outcomes of OAE testing in newborns 
and infants attending for their 6 weeks immunizations, at 
government health centres in Kampala, Uganda.
Subjects and Methods
This cross-sectional pilot study recruited 60 consecutive infants 
from two health centres in Kampala, Uganda. Thirty infants 
were newborn, aged 12 h–7 days and 30 were aged 4–8 weeks. 
The newborn group was recruited from the postnatal ward 
and the older infant group were attending the health center for 
their 6 weeks immunizations. The testing was performed using 
transient OAEs (TOAEs). Infants who failed the OAE testing 
were invited for two repeat OAE tests and then audiological 
diagnostics if required. Follow-up for any infant requiring further 
investigations or management was provided by the pediatric 
ear clinic at Kisugu health centre. The exclusion criteria for 
the groups were infants admitted to the neonatal unit and a 
birth weight <2.5 kg. Low birth weight was used as a proxy for 
prematurity as many mothers did not know their accurate gestation 
at birth. These babies were excluded due to the higher risk of 
auditory neuropathy that would not be detected using OAE testing.
The screening was performed using TOAEs with a Path 
Medical Solutions Sentiero device. For infants to pass the OAE 
test, they required a minimum signal to noise ratio of 6 dB in 
3 bands out of 1, 1.5, 2, 3 or 4 kHz in both ears.
The screening was performed by two medically qualified 
personnel from the UK. The staff received 2 days of training prior 
to commencing the study. Two local members of staff at each 
location were recruited to assist with translation for consenting 
and discussing results with parents when required. In addition 
to a verbal discussion, all families were given an information 
leaflet in either English or Luganda with education about normal 
developmental milestones for hearing and speech and contact 
details for the pediatric ear clinic at Kisugu health centre.
The screening was performed over a 1-month period, in 
Kisenyi and Kisugu health centres in Kampala. At both health 
centers, the quietest available space was found to perform the 
screening assessment. Repeat screening was performed in the 
same location as the original testing, however, audiological 
diagnostics were provided in a private clinic with follow-up at 
the Pediatric Ear Clinic at Kisugu Health Centre. For families 
attending the follow-up and requiring further audiological 
diagnostics travel expenses and the cost of the diagnostics 
were provided. Families who failed to attend for repeat testing 
were contacted by telephone on one occasion to schedule a new 
appointment for repeat testing. The study complied with the 
ethical requirements of the declaration of Helsinki. Data were 
analyzed using SPSS Statistics for Windows, Version 17.0. 
Chicago, IL, USA: SPSS Inc. Fisher's exact test was used to test 
for statistcial significance when comparing pass rates between 
the newborn and immunisation groups and to compare the pass 
rates between the newborn infants aged <24 hrs and ≥24 hrs.
Results
Sixty infants were enrolled in this study, of which 30 were 
newborn and 30 were from the immunization clinic. The 
newborns were aged between 12 and 149 h, median 21 h 
(interquartile range 17-29 h). The immunization group was aged 
between 28 and 56 days, median 43 days (interquartile range 
42-45 days). The median birth weight of the newborns was 3.2 
kg (interquartile range 2.9-3.6 kg) and for the immunization 
infants it was 3.4 kg (interquartile range 2.8-3.5 kg). 56.7% 
(17/30) (confidence interval 95% [CI] 39.2–72.6%) of the 
newborn infants passed the screening and 90.0% (27/30) (95% 
CI 73.6–97.3%) of the immunization infants passed the 
Walsh, et al.: Age for newborn screening for hearing loss in Uganda
Annals of Medical and Health Sciences Research | Nov-Dec 2015 | Vol 5 | Issue 6 | 405
screening, as shown in Figure 1, all CIs are at the 95% level. 
Following analysis using Fisher’s exact test this result was 
shown to be statistically significant at the 5% level (P < 0.01).
Of the 13 newborn infants who failed the first OAE test, 10 
were lost to follow-up during the re-testing process and three 
passed at re‑test. At the first repeat test, the attendance rate 
was 38.5% (5/13) and at the second repeat test, the attendance 
rate was 33.3% (1/3). Of the 10 newborn infants lost to 
follow‑up, 1 was aged ≥24 h and 9 were <24 h of age. From 
the immunization group only the first repeat test was required 
with an attendance rate of 66.7% (2/3,) shown in Figure 2.
Within the newborn group, there was a difference in the age 
distributions of the infants who passed and failed the screening 
test as shown in Figure 3. The median age of infants who 
passed was 25.6 h compared to 17.3 h for the infants who 
failed. Furthermore, of the 11 newborn infants aged ≥24 h of 
age 90.9% (10/11) (95% CI 60.1–99.9%) passed, compared 
with the 19 infants <24 h of age where 36.8% (7/19) (95% 
CI 19.1–56.1%) passed. Analysis with Fisher’s exact test 
shows these results are statistically significant at the 5% level 
(P < 0.01).
The mean duration of test time for each ear that passed the test 
was 35 s for the newborn infants and 25 s for the immunization 
infants. However, this difference did not reach statistical 
significance.
Discussion
The findings of this study reveal a statistically significant 
higher pass rate in the immunization infant group and newborns 
aged ≥24 h of age compared with the newborns aged <24 h. 
This finding correlates with other studies and could be the 
result of external ear debris and middle ear fluid, which is 
thought to resolve in the 1st days of life.[9-12] The suggestion 
that 24 h of age could be a threshold point where the pass 
rate for OAE testing significantly improves could be used to 
inform an NSHL protocol. This would ensure the best use of 
limited resources - an important factor for health services in 
Uganda. However, the small sample size of infants ≥24 h of 
age limits the strength of this conclusion and more research in 
this population is required to corroborate this finding.
The published pass rate, following a single OAE test, varies 
widely ranging from 59% to 90%. An average pass rate of 75% 
can be calculated using data from the meta-analysis conducted 
by Akinpelu et al. as well as other recent publications.[9,14-17] 
While our newborn pass rate of 56.7% reflects a lower than 
average pass rate, there are numerous factors that explain 
this. First, 63.3% of the newborn infants screened in this 
study were <24 h old, which is shown to be associated with 
Figure 1: Otoacoustic emission test results for the newborn and 
immunization infants
Figure 2: Outcomes of the 60 infants enrolled in the study
Walsh, et al.: Age for newborn screening for hearing loss in Uganda
406 Annals of Medical and Health Sciences Research | Nov-Dec 2015 | Vol 5 | Issue 6 |
a lower pass rate.[9-11,18,19] Our test environments had a high 
ambient noise level averaging 65–70 dB, which is also shown 
to negatively impact pass rates.[20,21] Finally, our pass criteria 
were more stringent than some of those used in the studies 
listed above which may also have contributed to a lower 
pass rate. Although the latter two factors were the same for 
both the newborn and immunization group, it may be that the 
combination of all three effects creates such a challenging 
environment for OAE testing that we see a threshold effect 
with a sudden decrease in pass rates.
The attendance rate for re-testing in this study was 66.7% for 
the immunization infants and 38.5% and 33.3% for the first and 
second re-test, respectively, for the newborn infants. Although 
the difference in attendence rate appears large between the 
two groups, the result is not statistically signigicant as the 
number of infants involved was very small. A low attendance 
rate for re-testing is a recognized problem of NSHL programs 
in developing coutries with programs in South Africa and 
Nigeria reporting the re-test attendance rates of between 40% 
and 48% per screening stage.[22,23] We encountered significant 
difficulties contacting the families by telephone to rearrange 
the repeat testing and found an appointment based service 
had limited success. A more frequent walk in service is likely 
to be more effective, as it offers families more flexibility and 
is more in keeping with how other health services in Uganda 
are organized. Improving the attendance rate for re-testing is 
crucial to being able to provide an effective NSHL service and 
the findings here suggest limiting the number of repeat tests 
would help address this issue.
Gaining the widest level of coverage is another key factor in 
a successful NSHL program and is heavily influenced by the 
platform from which screening is delivered. Within Kampala up 
to 92.7% of infants are delivered in a healthcare facility and the 
same number receives their BCG immunization by 8 weeks of 
age.[4,6] This suggests that NSHL in Kampala could be delivered 
from either a health care facility or an immunization clinic with 
similar levels of coverage. However, in Karamoja region only 
27% of infants are delivered in a health care facility whereas 
99.8% receive their BCG vaccination by 12–23 months of age. 
Although data is not available to indicate at specifically what 
age infants in Karamoja receive their BCG vaccination, the 
number who deliver in a health facility is so low that it would 
not be a viable platform for NSHL in this region.[4] A NSHL 
service would need to consider regional differences when 
deciding on the best platform to deliver a program and whether 
a service should be delivered from both to maximize coverage.
The disadvantage of screening infants at 4–8 weeks of age 
is the difficulty of organizing all the required testing and 
initiating interventions by 6 months of age, as recommended 
by the JCIH. However, at present there is no state funded 
hearing amplification service in Uganda and it is unlikely that 
this will change in the near future. For the average Ugandan 
these services are only accesible through partnerships with 
Nongovermental Organizations, the local healthcare system 
and private audiology services. It will require the further 
development of such partnerships to verify how long it would 
take an infant to navigate all the diagnostics and reach the 
point of initiating an intervention. Concerns that older infants 
may be more problematic to the screen as they are more active 
and the alert was not our experience. This is shown in the 
average 10 s shorter testing time per ear for the immunization 
infants. Furthermore, we feel this group of infants are easier 
to screen as the mothers are more mobile than those on the 
postnatal ward. This allows for a wider choice of testing 
venues which could be particularly helpful in minimizing the 
high background noise levels.
Amplification is not the only means of providing a life‑changing 
intervention. Better access to speech and language therapy, 
education for families, and suitable schooling environments 
can have a hugely beneficial effect on an individual with 
PCHL. In Uganda the stigma attached to deafness and 
disability prevents many families from accessing help when it 
becomes evident that a child is not developing appropriately. 
To diagnose children in early infancy provides unique access 
to these families and the opportunity to educate families about 
deafness and disability. However, no research has been done to 
explore the impact of an early diagnosis of PCHL in Uganda. 
While we hope an earlier diagnosis would lead to a better 
outcome for the child and family, it could negatively affect 
the early relationship between a mother and baby and result in 
rejection of the baby. Further research needs to be conducted to 
explore the impact of an early diagnosis of PCHL in a setting 
where access to audiological services for confirmation of the 
diagnosis and amplification servies is limited.
Conclusions
This study demonstrates a higher pass rate for OAE testing 
for infants ≥24 h of age compared to those <24 h of age. We 
Figure 3: Age distribution of the newborn infants according to 
result from otoacoustic emission testing. Two outliers in the “Pass” 
group (aged 100 and 149 h) are not shown on the graph for the 
purposes of presentation, but they have been included in the analysis 
and drawing of the graph
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suggest that 24 h of age could be the threshold where the pass 
rate for OAE testing significantly improves, however, further 
research needs to be done to corroborate this finding in this 
population group. These findings would support an NSHL 
program in Uganda that offers screening to infants ≥24 h 
of age. The screening platform needs to consider regional 
healthcare behaviors regarding the place of delivery and 
attendance at immunization clinic, to capture the highest 
number of infants and deliver the most cost-effective service. 
In addition, the pathway for audiological diagnostics and 
interventions needs to be clarified to see whether testing at 
4–8 weeks could be compatible with achieving interventions 
by 6 months of age.
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